drugset / Trial / NCT00139607
Parecoxib In Post Surgery (Hemicolectomy) Pain
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a phase III, multicenter, open label, pilot to evaluate the analgesic efficacy and safety of parecoxib 40 mg IV in the treatment of the pain following hemicolectomy in an optimal management of the surgical patient
Timeline
- Start
- 2002-09
- Primary completion
- —
- Completion
- 2005-01
Outcome
Outcome not reported
Stopped: “Please see detailed description for termination reason.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Parecoxib | Small molecule | 40 mg | Intravenous |
Indications
No indication recorded.